Preterm infants have an immature antioxidant system; however, they frequently require supplemental oxygen. Oxygen-free radicals cause both pulmonary and systemic inflammation, and they are associated with increased morbidity and mortality. Consequently, screening of metabolite profiles representing the amount of lipid peroxidation is considered of great relevance for the evaluation of in vivo oxidative stress and derived inflammation and damage. Ranges for total relative contents of isoprostanes (IsoPs), isofurans (IsoFs), neuroprostanes (NeuroPs), and neurofurans (NeuroFs) within targeted SpO 2 ranges were determined in urine samples of 254 preterm infants < 32 weeks of gestation within the frame of two randomized, controlled, and blinded clinical trials employing ultra-performance liquid chromatography-tandem mass spectrometry. A total of 536 serial urine samples collected during the first 4 weeks after birth in recruited infants who did not develop free radical associated conditions were analyzed. A reference range for lipid peroxidation byproducts, including isoprostanes, isofurans, neuroprostanes, and neurofurans, was calculated and possible correlations with neonatal conditions were investigated. Urinary elimination of isofurans in the first 4 days after birth correlated with later development of bronchopulmonary dysplasia. Our observations lead to the hypothesis that early urinary determination of lipid peroxidation byproducts, especially isofurans, is relevant to predict development of chronic lung conditions. Antioxid. Redox Signal. 23, 178-184.
Introduction
F etal-to-neonatal transition abruptly raises tissue oxygenation, thereby generating a burst of reactive oxygen species and resulting in physiologic oxidative stress. Preterm infants with immature lungs are predisposed to respiratory insufficiency and the need for oxygen therapy immediately after birth (8) . As a consequence, oxygen-free radicals are generated. Oxygen-free radicals may react with nonradical molecules in chain reactions, causing damage to DNA, proteins, and lipids or lead to the formation of DNA and protein adducts. Remarkably,
Innovation
A reference profile for urinary (noninvasive) lipid peroxidation biomarkers using a straightforward highthroughput ultra-performance liquid chromatographytandem mass spectrometry method in the newborn period has been developed. Preterm infants with high isofurans in the first days after birth are more prone to develop chronic lung conditions such as bronchopulmonary dysplasia.
free radical associated conditions such as bronchopulmonary dysplasia (BPD) causing severe morbidity and mortality have been described in the perinatal period (7) .
Isoprostanes (IsoPs) and isofurans (IsoFs) are chemically stable compounds formed in vivo via the nonenzymatic peroxidation of arachidonic acid (AA), associated with oxidant injury, and have been detected in fluids and tissues. IsoPs have been associated with normoxic, while IsoFs are generated under hyperoxic conditions. Docosahexaenoic acid (DHA) is a relevant structural component of the central nervous system. During lipid peroxidation, neuroprostanes (NeuroPs) and neurofurans (NeuroFs) arise from DHA oxidation in a similar manner to IsoPs and IsoFs from AA. NeuroPs and NeuroFs have been suggested as sensitive and specific markers of neuronal oxidative damage (1). FIG. 1. Mass spectrometry spectra of oxidized AA and DHA standard solutions. AA, arachidonic acid; DHA, docosahexaenoic acid. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars Analysis of lipid peroxidation products is highly complex due to the large number of metabolites, including isomers with highly similar molecular structures, physicochemical properties, and chromatographic behavior. Furthermore, for IsoFs, NeuroPs, and NeuroFs, no analytical standards are commercially available, hindering the implementation of their use as biomarkers (4) .
We propose a reliable, noninvasive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for recording profiles of relative total contents of IsoPs, IsoFs, NeuroPs, and NeuroFs in urine of preterm infants, enabling a semi-quantitative comparison between samples. We aimed at establishing a reference range of urinary lipid peroxidation byproducts in the first 4 weeks after birth (average period of clinical stabilization) in very preterm infants who did not develop free radical-associated conditions, and therefore this could be valuable information for a neonatologist. We investigated whether there were positive correlations between lipid peroxidation byproducts and free radical-associated conditions.
Results
The population consisted of preterm infants £ 32 weeks of gestation randomized to lower (30%; LowOx) or higher (60%-65%; HiOx) initial inspiratory fraction of oxygen (iFiO) in the delivery room (DR) (see Notes section) (5 Table 1 . No significant differences in oxidative stress biomarkers, mortality, or major perinatal morbidities were found for ( Table 2) .
MS/MS parameters for the detection of total IsoPs, IsoFs NeuroPs, and NeuroPs were selected from the spectra depicted in Figure 1 Solutions obtained via in vitro oxidation were subjected to a solid-phase extraction (SPE) procedure. Results comparing the analytical responses obtained with and without SPE showed recoveries of 91% -35%, 111% -39%, 86% -20%, and 93% -8%, for IsoPs, IsoFs, NeuroPs, and NeuroFs, respectively.
Total parameters were found above the limit of quantification (LOQ) (i.e., 10 times the area obtained from a blank injection) in almost all analyzed urine samples with 1.7%, 0.2%, 1.6%, and 3% of the samples giving concentrations below the LOQ for IsoPs, IsoFs, NeuroPs, and NeuroFs. Due to the lack of analytical standards, absolute concentrations could not be determined.
A total of 184 preterm infants pertaining to both groups (LowOx, n = 96; HiOx, n = 88) survived without free radicalrelated conditions at hospital discharge and were considered controls (5). Table 3 shows the mean and standard deviation of the urinary concentration of lipid peroxidation metabolites of controls according to the postnatal day of collection. In addition, values for IsoPs, IsoFs, NeuroPs, and NeuroFs at different postnatal days in controls and babies who later developed BPD were compared. Significant differences in IsoFs urinary elimination were found between controls and BPD babies in the first 4 days after birth. Figure 4 depicts the measured time profiles of the mean concentration and standard deviation values after birth for IsoPs, IsoFs, NeuroPs, and NeuroFs.
Discussion
Results for NeuroFs and NeuroPs (Fig. 1) confirmed NeuroPs 37 (61) 46 (51) 32 (34) 58 (42) 37 (65) 58 (44) 39 (27) 52 (33) 19 (18) 25 (14) 166 (291) (26) 20 (18) 24 (26) 39 (18) 28 (21) 38 (31) 29 (24) 25 (21) 44 (38) 54 (44) 39 (39) 51 (44) 50 (48) 43 (38) 23 (28) 34 (19) Results of preterm infants who did not develop free radical-associated conditions (controls) are compared with patients who developed BPD defined as need of oxygen supplementation at 36 weeks postconceptional age. Results are expressed as intensity of signal units/ml of urine and expressed as mean (standard deviation). This method aims at the assessment of the status of lipid peroxidation in preterm infants. The possibility of performing sequential peroxidation byproduct analysis noninvasively could aid the neonatologist in monitoring the metabolic status of the patients and the consequences of interventions. Interestingly, when stratifying the results of the measured biomarkers by collection time points, it was observed that the relative concentrations change along the first days and weeks after birth (Fig. 4) .
This study has relevant clinical implications. Recently, it has been acknowledged that preterm infants need some time to acquire a stable oxygenation after birth. Moreover, many very preterm infants require oxygen supplementation to keep oxygen saturation within established safety ranges (7) . In studies by Vento et al. (9) and Kapadia et al. (3) , preterm infants were randomized to an initial inspiratory fraction of oxygen of 30% versus 90%, and 21% versus 100%, respectively. In both studies (3, 9) , there was a correlation between the use of higher oxygen concentrations in the DR, increased oxidative stress biomarkers, and later development of BPD. Results in this study confirm these findings. Hence, preterm babies who later on developed BPD showed significantly higher urinary elimination of IsoFs in the analytical determinations performed in the first days after birth as did the study by Vento et al. (9) . 
